Market closed

ADMA Biologics/ADMA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ADMA Biologics

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Ticker

ADMA
Trading on

Industry

Biotechnology

Employees

624

ADMA Biologics Metrics

BasicAdvanced
$4B
Market cap
114.55
P/E ratio
$0.15
EPS
0.61
Beta
-
Dividend rate
$4B
0.61
$20.31
$3.06
6.6M
6.874
2.679
74.498
75.104
4.30%
15.07%
20.77%
114.55
11.751
21.05
21.51
58.694
58.69%
-177.75%
78.45%
-40.14%

What the Analysts think about ADMA Biologics

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for ADMA Biologics stock.

ADMA Biologics Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ADMA Biologics Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy ADMA

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ADMA Biologics stock?

ADMA Biologics (ADMA) has a market cap of $4B as of October 11, 2024.

What is the P/E ratio for ADMA Biologics stock?

The price to earnings (P/E) ratio for ADMA Biologics (ADMA) stock is 114.55 as of October 11, 2024.

Does ADMA Biologics stock pay dividends?

No, ADMA Biologics (ADMA) stock does not pay dividends to its shareholders as of October 11, 2024.

When is the next ADMA Biologics dividend payment date?

ADMA Biologics (ADMA) stock does not pay dividends to its shareholders.

What is the beta indicator for ADMA Biologics?

ADMA Biologics (ADMA) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.